Next Article in Journal
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology
Next Article in Special Issue
Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
Previous Article in Journal
Sonodynamic Therapy for Gliomas. Perspectives and Prospects of Selective Sonosensitization of Glioma Cells
Previous Article in Special Issue
Metabolic Signature of Hepatic Fibrosis: From Individual Pathways to Systems Biology

Mast Cells in Liver Fibrogenesis

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), University Hospital, RWTH Aachen University, D-52074 Aachen, Germany
Department of Internal Medicine III, University Hospital, RWTH Aachen University, D-52074 Aachen, Germany
Institute of Biochemistry and Molecular Immunology, Medical Faculty, RWTH Aachen University, D-52074 Aachen, Germany
Authors to whom correspondence should be addressed.
Cells 2019, 8(11), 1429;
Received: 14 October 2019 / Revised: 5 November 2019 / Accepted: 10 November 2019 / Published: 13 November 2019
Mast cells (MCs) are immune cells of the myeloid lineage that are present in the connective tissue throughout the body and in mucosa tissue. They originate from hematopoietic stem cells in the bone marrow and circulate as MC progenitors in the blood. After migration to various tissues, they differentiate into their mature form, which is characterized by a phenotype containing large granules enriched in a variety of bioactive compounds, including histamine and heparin. These cells can be activated in a receptor-dependent and -independent manner. Particularly, the activation of the high-affinity immunoglobulin E (IgE) receptor, also known as FcεRI, that is expressed on the surface of MCs provoke specific signaling cascades that leads to intracellular calcium influx, activation of different transcription factors, degranulation, and cytokine production. Therefore, MCs modulate many aspects in physiological and pathological conditions, including wound healing, defense against pathogens, immune tolerance, allergy, anaphylaxis, autoimmune defects, inflammation, and infectious and other disorders. In the liver, MCs are mainly associated with connective tissue located in the surrounding of the hepatic arteries, veins, and bile ducts. Recent work has demonstrated a significant increase in MC number during hepatic injury, suggesting an important role of these cells in liver disease and progression. In the present review, we summarize aspects of MC function and mediators in experimental liver injury, their interaction with other hepatic cell types, and their contribution to the pathogenesis of fibrosis. View Full-Text
Keywords: liver; inflammation; fibrosis; mast cell; degranulation; TGF-β; animal models; translational medicine; chymase; tryptase liver; inflammation; fibrosis; mast cell; degranulation; TGF-β; animal models; translational medicine; chymase; tryptase
Show Figures

Graphical abstract

MDPI and ACS Style

Weiskirchen, R.; Meurer, S.K.; Liedtke, C.; Huber, M. Mast Cells in Liver Fibrogenesis. Cells 2019, 8, 1429.

AMA Style

Weiskirchen R, Meurer SK, Liedtke C, Huber M. Mast Cells in Liver Fibrogenesis. Cells. 2019; 8(11):1429.

Chicago/Turabian Style

Weiskirchen, Ralf; Meurer, Steffen K.; Liedtke, Christian; Huber, Michael. 2019. "Mast Cells in Liver Fibrogenesis" Cells 8, no. 11: 1429.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop